{"id":"https://openalex.org/W2132000324","doi":null,"title":"Selective cytokine inhibitory drugs with enhanced antiangiogenic activity control tumor growth through vascular inhibition.","display_name":"Selective cytokine inhibitory drugs with enhanced antiangiogenic activity control tumor growth through vascular inhibition.","publication_year":2003,"publication_date":"2003-12-01","ids":{"openalex":"https://openalex.org/W2132000324","mag":"2132000324","pmid":"https://pubmed.ncbi.nlm.nih.gov/14678955"},"language":"en","primary_location":{"id":"pmid:14678955","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/14678955","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer research","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5088233000","display_name":"Michael Stanley Gee","orcid":"https://orcid.org/0000-0002-6117-5168","observed_orcids":["https://orcid.org/0000-0002-6117-5168"]},"institutions":[{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael S Gee","raw_affiliation_strings":["Department of Medicine and the Cancer Center, University of Pennsylvania Medical Center, Philadelphia, Pennsylvania 19104, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine and the Cancer Center, University of Pennsylvania Medical Center, Philadelphia, Pennsylvania 19104, USA","institution_ids":["https://openalex.org/I79576946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032057884","display_name":"Sosina Makonnen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sosina Makonnen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011340349","display_name":"Khalid Al-Kofahi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Khalid al-Kofahi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091168966","display_name":"Badri Roysam","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Badri Roysam","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045747037","display_name":"Faribourz Payvandi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Faribourz Payvandi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110152126","display_name":"Hon\u2010Wah Man","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hon-Wah Man","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112281139","display_name":"George W. Muller","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"George W Muller","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5068342797","display_name":"William M. F. Lee","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"William M F Lee","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.6599,"has_fulltext":false,"cited_by_count":15,"citation_normalized_percentile":{"value":0.60120868,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"63","issue":"23","first_page":"8073","last_page":"8"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12434","display_name":"Phosphodiesterase function and regulation","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/phosphodiesterase-4-inhibitors","display_name":"phosphodiesterase-4 inhibitors","score":0.949999988079071},{"id":"https://openalex.org/keywords/thalidomide-analogs","display_name":"thalidomide analogues","score":0.9819999933242798},{"id":"https://openalex.org/keywords/tumor-angiogenesis","display_name":"tumor angiogenesis","score":0.6700000166893005},{"id":"https://openalex.org/keywords/antiangiogenic-activity","display_name":"antiangiogenic activity","score":0.9319999814033508},{"id":"https://openalex.org/keywords/tumor-vascularity","display_name":"tumor vascularity","score":0.8009999990463257},{"id":"https://openalex.org/keywords/tumor-hypoxia","display_name":"tumor hypoxia","score":0.875},{"id":"https://openalex.org/keywords/tumor-cell-death","display_name":"cancer cell death","score":0.796999990940094},{"id":"https://openalex.org/keywords/pericyte-coverage","display_name":"pericyte coverage","score":0.8360000252723694},{"id":"https://openalex.org/keywords/antivascular-agents","display_name":"antivascular agents","score":0.7919999957084656},{"id":"https://openalex.org/keywords/tumor-growth-inhibition","display_name":"tumor growth inhibition","score":0.6320000290870667}],"concepts":[{"id":"https://openalex.org/C2780394083","wikidata":"https://www.wikidata.org/wiki/Q539568","display_name":"Angiogenesis","level":2,"score":0.7033934593200684},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.606904149055481},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.59874027967453},{"id":"https://openalex.org/C2779609412","wikidata":"https://www.wikidata.org/wiki/Q203174","display_name":"Thalidomide","level":3,"score":0.5643770694732666},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5352175235748291},{"id":"https://openalex.org/C2778608917","wikidata":"https://www.wikidata.org/wiki/Q6787805","display_name":"Matrigel","level":3,"score":0.48274892568588257},{"id":"https://openalex.org/C31573885","wikidata":"https://www.wikidata.org/wiki/Q304484","display_name":"Programmed cell death","level":3,"score":0.444460928440094},{"id":"https://openalex.org/C178596483","wikidata":"https://www.wikidata.org/wiki/Q7916472","display_name":"Vascularity","level":2,"score":0.41660216450691223},{"id":"https://openalex.org/C7836513","wikidata":"https://www.wikidata.org/wiki/Q1641506","display_name":"Hypoxia (environmental)","level":3,"score":0.4152246415615082},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.410694420337677},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.38380664587020874},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3465022146701813},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3151822090148926},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.29824602603912354},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.2446824312210083},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.20833194255828857},{"id":"https://openalex.org/C540031477","wikidata":"https://www.wikidata.org/wiki/Q629","display_name":"Oxygen","level":2,"score":0.0},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.0},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002455","descriptor_name":"Cell Division","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004730","descriptor_name":"Endothelium, Vascular","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D008807","descriptor_name":"Mice, Inbred BALB C","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008809","descriptor_name":"Mice, Inbred C3H","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009374","descriptor_name":"Neoplasms, Experimental","qualifier_ui":"Q000098","qualifier_name":"blood supply","is_major_topic":true},{"descriptor_ui":"D009374","descriptor_name":"Neoplasms, Experimental","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009374","descriptor_name":"Neoplasms, Experimental","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D009389","descriptor_name":"Neovascularization, Pathologic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D013792","descriptor_name":"Thalidomide","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D013792","descriptor_name":"Thalidomide","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D015687","descriptor_name":"Cell Hypoxia","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D016207","descriptor_name":"Cytokines","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:14678955","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/14678955","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer research","raw_type":"Journal Article"},{"id":"mag:2132000324","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/14678955","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9476000070571899,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G3957847362","display_name":"TUMOR PHYSIOLOGICAL EFFECTS OF ANGIOGENESIS INHIBITION","funder_award_id":"R01CA083042","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G7189457772","display_name":"Mechanisms of Tumor Rejection","funder_award_id":"R01CA077851","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":34,"referenced_works":["https://openalex.org/W144837917","https://openalex.org/W184065906","https://openalex.org/W1528335004","https://openalex.org/W1555764667","https://openalex.org/W1897772287","https://openalex.org/W1910119464","https://openalex.org/W1970124798","https://openalex.org/W1974520996","https://openalex.org/W1977071537","https://openalex.org/W1985147506","https://openalex.org/W1988307856","https://openalex.org/W1993594765","https://openalex.org/W1998478088","https://openalex.org/W1999334756","https://openalex.org/W2010925210","https://openalex.org/W2013045129","https://openalex.org/W2017377634","https://openalex.org/W2018803923","https://openalex.org/W2022943800","https://openalex.org/W2027412145","https://openalex.org/W2046118145","https://openalex.org/W2066936999","https://openalex.org/W2071895235","https://openalex.org/W2100961570","https://openalex.org/W2119810076","https://openalex.org/W2122596233","https://openalex.org/W2129539691","https://openalex.org/W2151516574","https://openalex.org/W2159746652","https://openalex.org/W2162559503","https://openalex.org/W2316160054","https://openalex.org/W2339981418","https://openalex.org/W2398378119","https://openalex.org/W4313376856"],"related_works":["https://openalex.org/W7096999060","https://openalex.org/W2556153975","https://openalex.org/W2171194005","https://openalex.org/W2008641990","https://openalex.org/W749038731","https://openalex.org/W2091098825","https://openalex.org/W2106601043","https://openalex.org/W143440435","https://openalex.org/W2131362405","https://openalex.org/W2033013877"],"abstract_inverted_index":{"Selective":[0],"cytokine":[1],"inhibitory":[2],"drugs":[3],"(SelCIDs)":[4],"are":[5,147],"a":[6,15,97],"novel":[7,148],"class":[8],"of":[9,59,100,103,132],"phosphodiesterase":[10],"4":[11],"inhibitors":[12],"discovered":[13],"during":[14],"thalidomide":[16],"analog":[17],"discovery":[18],"program.":[19],"These":[20,53],"analogs":[21,35,54,134,146],"were":[22,39],"evaluated":[23],"for":[24],"their":[25],"ability":[26],"to":[27,96,120],"inhibit":[28],"tumor":[29,81,112,115,141],"angiogenesis,":[30],"vascularity,":[31],"and":[32,37,62,84],"growth.":[33],"Two":[34],"(CC-7034":[36],"CC-9088)":[38],"identified":[40],"that":[41,107,130,144],"had":[42],"enhanced":[43],"antiangiogenic":[44],"activity":[45],"in":[46,88,137],"Matrigel":[47],"assays":[48],"compared":[49],"with":[50,79,127,151],"parental":[51],"thalidomide.":[52],"also":[55],"inhibited":[56],"the":[57,128,133,140],"growth":[58,68],"established":[60],"K1735":[61],"RENCA":[63],"murine":[64],"tumors.":[65],"Tumors":[66],"whose":[67],"was":[69,118,135],"suppressed":[70],"by":[71,91],"SelCID":[72,92],"treatment":[73,93],"exhibited":[74],"decreased":[75],"vessel":[76],"density":[77],"together":[78],"increased":[80],"cell":[82,116],"hypoxia":[83],"death.":[85],"The":[86],"decrease":[87],"vascularity":[89],"produced":[90],"is":[94],"attributed":[95],"selective":[98],"loss":[99],"vessels":[101],"devoid":[102],"pericyte":[104],"coverage,":[105],"suggesting":[106],"these":[108,145],"agents":[109,150],"target":[110],"immature":[111],"vessels.":[113],"That":[114],"death":[117],"localized":[119],"relatively":[121],"avascular":[122],"or":[123],"hypoxic":[124],"areas,":[125],"coupled":[126],"fact":[129],"none":[131],"cytotoxic":[136],"vitro":[138],"against":[139],"cells,":[142],"demonstrates":[143],"antivascular":[149],"potent":[152],"antitumor":[153],"activity.":[154]},"counts_by_year":[{"year":2016,"cited_by_count":1},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}